bf/NASDAQ:LPTX_icon.jpeg

NASDAQ:LPTX

Leap Therapeutics, Inc.

  • Stock

USD

Last Close

0.41

06/11 22:17

Market Cap

75.00M

Beta: 0.74

Volume Today

217.02K

Avg: 600.93K

PE Ratio

−1.13

PFCF: −1.85

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
average inventory
15K
-
15K
0%
average payables
578K
-
227.50K
60.64%
1.81M
695.38%
2.92M
61.56%
3.10M
6.05%
4.08M
31.43%
3.64M
10.58%
3.45M
5.24%
4.92M
42.57%
6.06M
23.12%
average receivables
300K
-
308.50K
2.83%
1.70M
452.35%
2.46M
44.19%
1.29M
47.50%
510.50K
60.43%
129K
74.73%
631K
389.15%
1.64M
160.54%
1.05M
36.16%
book value per share
38.95
-
15.75
59.56%
-106.71
777.45%
12.13
111.37%
6.49
46.54%
-0.77
111.94%
7.86
1,115.29%
12.57
59.86%
0.52
95.86%
0.00
99.43%
capex per share
-0.19
-
-0.01
96.32%
-0.15
2,079.34%
-0.07
54.44%
-0.04
-
capex to depreciation
-0.35
-
-0.03
92.67%
-5.76
22,652%
-1.33
76.85%
-2.13
-
capex to operating cash flow
0.01
-
0.00
95.14%
0.01
827.34%
0.00
49.13%
0.00
-
capex to revenue
cash per share
38.93
-
16.16
58.48%
0.84
94.78%
28.09
3,227.20%
11.51
59.02%
1.72
85.03%
8.78
409.39%
13.39
52.56%
0.58
95.68%
0.00
99.40%
days of inventory on hand
days payables outstanding
days sales outstanding
17.76
-
289.32
1,528.77%
debt to assets
4.69
-
0.14
-
0.01
92.63%
0.00
60.82%
0.01
142.29%
0.00
62.67%
debt to equity
-0.30
-
-0.59
-
0.01
102.02%
0.00
63.26%
0.01
164.95%
0.00
62.18%
dividend yield
0.01
-
0.00
84.01%
earnings yield
-0.27
-
-0.16
42.33%
-0.35
120.59%
-0.52
49.76%
-0.82
57.30%
-1.30
59.03%
-0.21
84.15%
-0.15
29.19%
-0.11
26.60%
-0.00
99.10%
enterprise value
82.38M
-
113.11M
37.30%
103.31M
8.67%
31.43M
69.57%
12.00M
61.81%
22.43M
86.83%
81.97M
265.48%
163.63M
99.62%
444.75M
171.81%
84.57B
18,915.54%
enterprise value over ebitda
-4.18
-
-5.53
32.40%
-4.24
23.34%
-0.98
76.96%
-0.41
58.40%
-0.68
67.25%
-2.91
327.54%
-4.07
40.14%
-8.27
103.10%
-971.64
11,650.66%
ev to operating cash flow
-4.57
-
-5.78
26.34%
-4.08
29.42%
-1.42
65.17%
-0.46
67.52%
-0.83
80.79%
-3.16
278.79%
-4.65
47.38%
-9.07
94.85%
-1.93K
21,215.07%
ev to sales
54.65
-
109.08
99.62%
free cash flow per share
-15.38
-
-11.49
25.31%
-27.13
136.20%
-24.23
10.68%
-18.41
24.05%
-11.96
35.04%
-4.38
63.41%
-4.10
6.37%
-0.43
89.43%
-0.00
99.51%
free cash flow yield
-0.20
-
-0.15
25.31%
-0.35
136.20%
-0.39
12.51%
-0.92
136.98%
-1.07
16.01%
-0.19
81.79%
-0.13
34.98%
-0.10
23.88%
-0.00
99.46%
graham net net
37.07
-
15.52
58.13%
-3.48
122.44%
9.93
385.16%
4.96
50.09%
-2.29
146.16%
7.48
427.11%
12.33
64.67%
0.49
96.02%
0.00
99.42%
graham number
137.12
-
66.22
51.71%
255.98
286.57%
94.12
63.23%
48.86
48.08%
15.93
67.39%
28.64
79.78%
36.57
27.68%
2.37
93.51%
0.02
99.32%
income quality
0.71
-
0.93
31.07%
0.99
6.54%
0.74
24.67%
1.13
51.09%
0.82
27.32%
0.94
15.38%
0.87
8.18%
0.90
3.71%
0.54
40.17%
intangibles to total assets
0.01
-
0
100%
0
0
0
0
0
0
0
0
interest coverage
-4.79
-
-1.17K
24,384.19%
-22.32
98.09%
-267.37
1,097.88%
-1.62K
505.33%
-1.45K
10.14%
-731.77
49.69%
-1.01K
38.07%
-1.05K
4.04%
interest debt per share
3.68
-
0.01
99.71%
33.55
317,791.75%
0.13
99.61%
0.01
89.83%
0.46
3,358.02%
0.10
78.55%
0.06
40.35%
0.01
89.12%
0.00
99.80%
inventory turnover
invested capital
-0.30
-
-0.59
-
0.01
102.02%
0.00
63.26%
0.01
164.95%
0.00
62.18%
market cap
93.25M
-
134.07M
43.79%
73.82M
44.94%
57.17M
22.56%
28.29M
50.52%
25.29M
10.59%
133.49M
427.77%
278.07M
108.31%
509.58M
83.25%
84.64B
16,510.43%
net current asset value
44.23M
-
26.64M
39.77%
-2.43M
109.11%
9.71M
500.04%
7.42M
23.58%
-4.96M
166.77%
44.55M
998.99%
106.85M
139.82%
56.46M
47.16%
58.91M
4.34%
net debt to ebitda
0.55
-
1.02
86.03%
-1.21
218.03%
0.80
166.12%
0.55
31.09%
0.09
84.25%
1.83
2,003.56%
2.85
55.95%
1.21
57.68%
0.81
32.91%
net income per share
-21.45
-
-12.37
42.33%
-27.29
120.59%
-32.45
18.89%
-16.36
49.58%
-14.57
10.94%
-4.64
68.17%
-4.73
1.97%
-0.48
89.80%
-0.00
99.17%
operating cash flow per share
-15.19
-
-11.48
24.42%
-26.98
135.01%
-24.16
10.43%
-18.41
23.83%
-11.91
35.28%
-4.38
63.27%
-4.10
6.37%
-0.43
89.43%
-0.00
99.51%
payables turnover
receivables turnover
20.55
-
1.26
93.86%
research and ddevelopement to revenue
13.62
-
21.44
57.47%
return on tangible assets
-0.53
-
-0.75
42.64%
-3.97
429.51%
-1.02
74.23%
-1.21
18.59%
-4.42
264.14%
-0.51
88.54%
-0.34
31.98%
-0.78
125.45%
-1.12
44.06%
revenue per share
0.25
-
0.17
30.87%
roe
-0.55
-
-0.79
42.60%
0.26
132.56%
-2.67
1,145.64%
-2.52
5.69%
18.81
845.91%
-0.59
103.14%
-0.38
36.21%
-0.93
146.53%
-1.35
45.96%
roic
-0.45
-
-0.79
74.45%
0.46
158.21%
-2.89
729.03%
-3.35
15.88%
-110.39
3,190.77%
-0.60
99.46%
-0.38
36.34%
-0.95
148.42%
-1.43
51.81%
sales general and administrative to revenue
6.41
-
7.18
11.96%
shareholders equity per share
38.95
-
15.75
59.56%
-106.71
777.45%
12.13
111.37%
6.49
46.54%
-0.77
111.94%
7.86
1,115.29%
12.57
59.86%
0.52
95.86%
0.00
99.43%
stock based compensation to revenue
1.74
-
2.32
33.05%
tangible asset value
45.94M
-
26.87M
41.50%
11.12M
-
9.18M
17.47%
-1.75M
119.06%
46.65M
2,767.30%
107.89M
131.26%
58.87M
45.44%
60.14M
2.17%
tangible book value per share
38.72
-
15.75
59.32%
12.13
-
6.49
46.54%
-0.77
111.94%
7.86
1,115.29%
12.57
59.86%
0.52
95.86%
0.00
99.43%
working capital
44.23M
-
26.64M
39.77%
-32.13M
220.61%
21.57M
167.15%
10.87M
49.61%
-4.25M
139.05%
44.90M
1,157.76%
106.89M
138.05%
56.73M
46.93%
58.91M
3.86%

All numbers in USD (except ratios and percentages)